Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

Also called NCT03547323

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 156 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03547323
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03547323. Randomized; no masking; primary purpose treatment. Start 2018-09-14 (actual); primary completion 2019-06-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer
Condition
End Stage Renal Disease
Intervention (Device)
Theranova 400 Dialyzer
Intervention (Device)
FX80 Dialyzer
Lead sponsor
Vantive Health LLC (class: industry)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct03547323
Content hash
ebe791410b7153ed248fcefe09d5f89317e2900d2437699ca6b9aa30b7804677